TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00006148 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00006148 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03912974 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT06066073 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00071877 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT00561275 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03166228 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01269216 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02149628 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02149628 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04460729 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04372446 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study NCT04372446 — Predictive Biomarker (PRD): ABCC6 mRNA
Genes: ABCC6; ARA; MRP6
Study NCT01202643 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00077597 — Surrogate Endpoint (SUR): Hemoglobin response rate
Study NCT04550962 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03894657 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01707810 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03652467 — Predictive Biomarker (PRD): Liver iron
Study NCT02443389 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00902174 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00902174 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01569334 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study NCT01569334 — Predictive Biomarker (PRD): CX3CR1 mRNA
Genes: CX3CR1; CMKBRL1; GPR13
Study NCT01569334 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT01569334 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study NCT02525081 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00195884 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00195884 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03728959 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT01657214 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00245245 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT00095394 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02457442 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03532269 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04296422 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04304430 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04304430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01061112 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03403309 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00517569 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00675051 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT02705274 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02705274 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03136237 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT00318474 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT00318474 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03544307 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00903331 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02905487 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02905487 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00616694 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00023036 — Predictive Biomarker (PRD): SLC26A4 mRNA
Genes: SLC26A4; PDS
Study NCT00302380 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT02752113 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03449186 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT03898128 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04183088 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04619693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04619693 — Predictive Biomarker (PRD): SCGB1A1 mRNA
Genes: SCGB1A1; CC10; CCSP; UGB
Study NCT04619693 — Predictive Biomarker (PRD): BAK1 mRNA
Genes: BAK1; BAK; BCL2L7; CDN1
Study NCT04619693 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04619693 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT02110303 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT03650790 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT02351284 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02068872 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03040986 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00171366 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01743521 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT00147082 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study NCT01732133 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05027659 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01921101 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03806075 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT03806075 — Predictive Biomarker (PRD): STK11 mRNA
Genes: STK11; LKB1; PJS
Study NCT03806075 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT03203733 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01024946 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT05859919 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03273868 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00611715 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00853112 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00853112 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03048747 — Surrogate Endpoint (SUR): Serum sodium
Study NCT04486404 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00129376 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04166305 — Predictive Biomarker (PRD): SCN1A mRNA
Genes: SCN1A; NAC1; SCN1
Study NCT04166305 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT01005927 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT03496766 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT02048488 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02048488 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT02048488 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT02048488 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study NCT01920087 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00683618 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04194125 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT02788058 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01364909 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01364909 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00941707 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03171636 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03171636 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04669509 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04669509 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04669509 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04669509 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT02939768 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02939768 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02447809 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT01719367 — Predictive Biomarker (PRD): ADRB1 mRNA
Genes: ADRB1; ADRB1R; B1AR
Study NCT00005213 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02183883 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02183883 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03454308 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03999151 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT03784742 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04136106 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00679211 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02520102 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02874573 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02874573 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00532064 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01914900 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00915018 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02813109 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02813109 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01510301 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00047918 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00004990 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01631539 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02131571 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05277298 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04411043 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT04411043 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT04411043 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT04411043 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04411043 — Predictive Biomarker (PRD): TCL1A mRNA
Genes: TCL1A; TCL1
Study NCT04411043 — Predictive Biomarker (PRD): IL2RG mRNA
Genes: IL2RG
Study NCT04411043 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT04411043 — Predictive Biomarker (PRD): JAK3 mRNA
Genes: JAK3
Study NCT04411043 — Predictive Biomarker (PRD): STAT5B mRNA
Genes: STAT5B
Study NCT04411043 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT04411043 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT03602859 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03602859 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01043445 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00726713 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02677857 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00376012 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00900484 — Predictive Biomarker (PRD): RTEL1 mRNA
Genes: RTEL1; C20orf41; KIAA1088; NHL
Study NCT01332006 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04135391 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04135391 — Safety Biomarker (SAF): BDNF
Study NCT02510989 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT04677803 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00355615 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03933306 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02184962 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT00926380 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04321291 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02460094 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00403390 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT01791101 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT01899729 — Predictive Biomarker (PRD): TLR8 mRNA
Genes: TLR8; UNQ249/PRO286
Study NCT01899729 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT01808040 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02551029 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study NCT01117038 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04672915 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01963715 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03381469 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01067079 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04306653 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02048462 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT02048462 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03783819 — Predictive Biomarker (PRD): TRPC6 mRNA
Genes: TRPC6; TRP6
Study NCT04972435 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study NCT04088110 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04088110 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04088110 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04088110 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03311269 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT02023905 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03757377 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00718718 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04615429 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01526928 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01526928 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00968006 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00968006 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00642824 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01915862 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03046680 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04352933 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00831012 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03088189 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00294866 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04317612 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02770391 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HSD3B1 mRNA
Genes: HSD3B1; 3BH; HSDB3A
Study NCT03097276 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03246529 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05166005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02812875 — Predictive Biomarker (PRD): VSIR mRNA
Genes: VSIR; C10orf54; SISP1; VISTA; PP2135; UNQ730/PRO1412
Study NCT03009968 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT02215005 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02242383 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03140462 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT03140462 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03140462 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT03140462 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT04457232 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT00406900 — Predictive Biomarker (PRD): MIA mRNA
Genes: MIA
Study NCT01749163 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04228406 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00578578 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04518488 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT02490501 — Safety Biomarker (SAF): Fibroblast growth factor 1
Genes: FGF1
Study NCT00626015 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT02318446 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02573324 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02573324 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02386501 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01579630 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01232855 — Predictive Biomarker (PRD): S100A10 mRNA
Genes: S100A10; ANX2LG; CAL1L; CLP11
Study NCT01099436 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03376685 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00144456 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03515005 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00066846 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00888316 — Predictive Biomarker (PRD): Liver iron
Study NCT00901849 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00901849 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03089723 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06086483 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06086483 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT03354624 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04399018 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT04021082 — Predictive Biomarker (PRD): SYK mRNA
Genes: SYK
Study NCT04021082 — Predictive Biomarker (PRD): ITK mRNA
Genes: ITK; EMT; LYK
Study NCT02915913 — Safety Biomarker (SAF): BDNF
Study NCT00620633 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT04061070 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00185133 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03462537 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02194829 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study NCT03532425 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05104398 — Predictive Biomarker (PRD): SDC1 mRNA
Genes: SDC1; SDC
Study NCT04093986 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00767585 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01619267 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01619267 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04070495 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01252524 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03765203 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03765203 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02997683 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00875342 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00875342 — Safety Biomarker (SAF): BDNF
Study NCT01970059 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05204433 — Predictive Biomarker (PRD): SFRP1 mRNA
Genes: SFRP1; FRP; FRP1; SARP2
Study NCT01649752 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02321267 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD